Health Creators

Health Creators

di Livia Lifes

Imprenditoria Medicina

E020: Sebastian Gruber: From Mckinsey to Healthtech CEO

Half of the world lacks access to essential health services (WHO-2017). For those that have insurance, medical claims can often be a lengthy process with 75% taking 2 months or longer (Klipfolio-2022). Sebastian is on a mission to reinvent the claims process with Hi.Health, a healthcare financial system that partners with insurance providers that flips the way we claim - allowing patients to pay via insurance as a first port of call. In this episode, Sebastian and I discuss his journey from McKinsey to Healthtech CEO and his vision for the future of medical claims. #ceo #podcast #InnovativeSolutions #StreamlinedClaims #healthtech Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

E019: Marvin Abert: The Future of STI Testing

More than 1 million sexually transmitted infections (STIs) are acquired every day worldwide, the majority of which are asymptomatic (WHO,2022). Each year there are an estimated 374 million new infections with 1 of 4 curable STIs: chlamydia, gonorrhoea, syphilis and trichomoniasis. STIs have a direct impact on sexual and reproductive health through stigmatization, infertility, cancers and pregnancy complications and can increase the risk of HIV. STI testing is often expensive and not widely accessible. In addition, the time it takes for results to be received is often long. As a result, follow-up can be impeded and care or treatment can be incomplete. Not knowing can also increase the risk of transmission. Marvin is on a mission to revolutionize sexual health through Remi Health, at-home STI testing currently serving the German market. #ceo #podcast #healthtech #std #testing Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

E018: Amisha Kalra: Is ADHD a Superpower?

The worldwide prevalence of adult ADHD is estimated at 2.8% (Song-2021). While ADHD has traditionally been seen as a disability, more recently the normalization of the condition has led to increased self-diagnosis and the belief that ADHD is a 'superpower'. In this episode, Amisha Kalra - founder of Clicks, and part of Science Entrepreneur Club, answers our questions on ADHD and the importance of early diagnosis in children to enable improved learning and development. Watch: https://www.youtube.com/@HealthCreators/ Checkout: Neuroute - copilot for clinical trials: https://www.neuroute.co/ Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes

E017: Annabel de Gheldere: The Future of Female Food

85% of women suffer from hormonal imbalances, with symptoms affecting their daily lives, energy levels, sleep, stress, emotions, body temperature, cognitive functions, and much more. Annabel is on a mission to transform hormonal health by using data points to provide precision nutrition for women. #ceo #podcast #healthtech #femalehealth Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

Fireside Chats: Jeffrey Hausfeld

Dr. Jeffrey Hausfeld is the CMO at Biofactura, and Managing Director of FMS Financial Solutions, a national debt collection and debt acquisition firm specializing in medical and multi-family housing debt collection. He is also the founder of the Society of Physician Entrepreneurs, and takes an active roles in supporting physicians that want to transition into entrepreneurship. 👉 Watch Now: https://www.youtube.com/watch?v=Bla8TrVfgvkFollow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes Neuroute - copilot for clinical trials: https://www.neuroute.co

E016: Stephen Keenan: From Deliveroo to DTx

Chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide, causing 3.23 million deaths in 2019. In 2023, the WHO estimates the pooled global prevalence of COPD to be 15.7% in men and 9.93% in women. Despite such high prevalence, many COPD sufferers are left with no solution debilitated by an inability to maintain their normal standard of life. Stephen is on a mission to improve quality of life for COPD patients - combining his learnings from building consumer apps at Deliveroo with healthcare machine learning to change the way COPD patients interact with their health. Checkout: https://www.joinfilter.co/ #copd #ceo #podcast #healthtech Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

E015: Mike Romanos: Building the Future of Biotech Spinouts

In 2022, it was estimated that up to 90% of startups failed within the first 5 years of forming. Against these odds, Dr. Mike Romanos successfully built 3 world-class biotech spinouts. After raising a Series C in his previous startup and 35 years in industry, Mike has joined Imperial as Associate Dean for Enterprise in the Faculty of Medicine. In his role at Imperial as well as at LifeArc, Mike aims to make spinning out more accessible enabling more academics to build world-class biotech companies. #biotechnology #ceo #podcast #healthtechFollow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

E014: Emilė Radytė: Solving PMS with Neurotechnology

90% of women of reproductive age experience several premenstrual symptoms (PMS) varying from mild to severe. PMS can be debilitating for women. It can prevent us from working or living life normally yet, so few solutions exist for it. Emilė is on a mission to eradicate PMS and solve critical issues in women's health through wearable neurotechnology. By making neurotechnology tailored to women, we can improve the accessibility and usability of medical devices for female health. Watch: https://www.youtube.com/watch?v=fkiQ9we7mv8Follow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co

E013: Jason Foster: How to be a CEO

In this episode, Jason Foster deep dives into how to be a CEO through his own journey of being onboarded as CEO of Ori Biotech following prior success in healthcare companies. In many cases, companies in the science and healthcare space are run by scientists. Although there are a lot of benefits to being a scientist CEO, often at the growth stage scientist founders bring on experienced CEOs (like Jason) to guide the company to its next stages. Jason is on a mission to foster and develop the healthcare ecosystem through Ori Biotech and a number of startups he advises. Youtube - https://youtu.be/2r0Mar1-uZEFollow: Neuroute: copilot for clinical trials https://www.neuroute.coTwitter: https://twitter.com/livialifesLinkedin: www.linkedin.com/in/livialifes

E012: Emmanuel Hui: How to Raise Venture Financing from China

From dorm room biotech to VC, in this episode, Emmanuel Hui and I dive into his journey building Moogene from zero to IPO, how VCs consider deals and how a healthcare founder can raise venture financing from China. Emmanuel is on a mission to help science entrepreneurs go from zero to one. Currently, as CEO of Tiger Jade Pebble Accelerator, Emmanuel works with one of the biggest CROs in Asia to help science founders commercialize their products. Resources:Neuroute - copilot for clinical trials https://www.neuroute.co/Youtube - https://youtu.be/2r0Mar1-uZEFollow: Twitter: https://twitter.com/livialifesLinkedin: www.linkedin.com/in/livialifes

3 di 5